C3 and lobular neoplasia: In the subgroup of biopsy-concurrent LN patients, urinary ALCAM was significantly increased in patients with proliferative LN compared to those with membranous LN and outperformed conventional biomarkers (anti-dsDNA antibody, C3, C4, 24-h urine protein) in discriminating the two different types of LN.